Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
about
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligoThe "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblasts.The macrophage foam cell as a target for therapeutic intervention.Brain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic model.Fluvastatin and fluvastatin extended release: a clinical and safety profile.Pleiotropic vasoprotective effects of statins: the chicken or the egg?Pleiotropic effects of statins: new therapeutic targets in drug design.Immunomodulatory effects of rosuvastatin on hepatic ischemia/reperfusion induced injury.[Managing comorbidities of inflammatory rheumatic diseases].Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis.Aneurysms: leukotrienes weaken aorta from the outside.Treatment with fluvastatin rapidly modulates, via different pathways, and in dependence on the baseline level, inflammation in hemodialysis patients.Inhibition of Atherosclerosis Progression, Intimal Hyperplasia, and Oxidative Stress by Simvastatin and Ivabradine May Reduce Thoracic Aorta's Stiffness in Hypercholesterolemic Rabbits.Atorvastatin affects interleukin-2 signaling by altering the lipid raft enrichment of the interleukin-2 receptor beta chain.The relationship between lymphocyte-to-monocyte ratio and saphenous vein graft patency in patients with coronary artery bypass graft.Effects of pravastatin treatment on blood pressure regulation after renal transplantation.Therapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives
P2860
Q24794301-32316A44-875A-4157-BC74-A196E010D4CBQ24796000-BBFBB084-D256-4AFC-90CA-03EE3C464E48Q34538139-AA2EF1D2-D1B9-4927-AFF9-D259D8CCC6F2Q34986351-83B1885E-69E1-4527-B05A-45A40E4129A7Q35128709-00A9BAB2-C902-456D-ADB4-8403AE9651BBQ35879055-1E0F0B37-E237-4696-AEC7-37980C832121Q37403235-FFA3A25D-9D62-4566-B30C-CDF647BCBF58Q38825843-D2FC7C39-AD05-4218-9A65-C809F3E10BE5Q43178503-EFF11EC0-2B57-4C9D-B975-3DC82C75B00AQ44393048-571D990C-BB4C-4163-A64F-8577AF5DE629Q45034871-31BB85F8-971C-49C6-AED9-6C8D7016CC88Q45039033-38B4F2C7-6FB6-4EED-B530-3FBE2305FE82Q45158969-7458A1D5-A12D-4742-A0B9-55E996CC41A5Q46632831-6A5A0E40-6445-40B7-BB3C-7A5B9D9189D7Q46737891-045ECFD9-97A6-450B-9B2F-FD98CD4C98F2Q49613427-BDE9AEA0-05A1-49F9-BC39-A248579C80B3Q53817803-7C749AE7-4618-41BB-B38E-8B923B2B1784Q57703131-452DD258-9233-4B08-83AC-ADEDF4E1473A
P2860
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
@ast
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
@en
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
@nl
type
label
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
@ast
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
@en
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
@nl
prefLabel
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
@ast
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
@en
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
@nl
P1476
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
@en
P2093
Wulf Palinski
P304
P356
10.1097/01.ASN.0000018400.39687.8C
P577
2002-06-01T00:00:00Z